What is the Hypomanic Personality Scale (HPS-6) studying for Bipolar Disorder?

The HPS-6 is being studied to help identify individuals at high risk for Bipolar Disorder by providing a brief, specific screening tool. This study aims to adapt and validate the scale for use in Romania to improve early recognition and diagnosis. The research is sponsored by Babes-Bolyai University and focuses on creating an effective tool for the Romanian population.

Who may be eligible for this Bipolar Disorder clinical trial?

Adults aged 18 to 50 who are native Romanian speakers may be eligible. Participants should not have a current high risk of suicide or high levels of substance or alcohol use disorders. They also need to have intact cognitive abilities to understand the assessment items. Please review eligibility criteria for more details.

Is there any cost to participate in this Bipolar Disorder clinical trial?

Study-related care, including the study assessments and all trial visits, is provided at no cost. However, personal travel expenses to attend study visits may vary and are not guaranteed to be covered. Participants should plan accordingly for any travel costs.

Actively Recruiting

Phase 1

Phase 2

Age: 18Years - 50Years

All Genders

Healthy Volunteers

ID07399626

Validation and Adaptation of the Hypomanic Personality Scale HPS-6 for Romanian Adults Aged 18 to 50

Led by Babes-Bolyai University · Updated on 2026-02-10

Participants Needed

Research Sites

8 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating the Hypomanic Personality Scale - 6 HPS-6 to adapt and validate it for the Romanian population, aiming to improve screening for individuals at high risk for Bipolar Disorder BD. This chronic and serious condition affects about 2.4% of people worldwide, but in Romania, the reported prevalence is low due to stigma and healthcare system challenges. The study seeks to provide a brief, reliable tool to help identify BD earlier and support better diagnosis and treatment. Participants will be assessed using the HPS-6 along with several other questionnaires related to mood, behavior, impulsivity, affective lability, and self-rating scales. The study includes two groups one for piloting the scale and exploratory factor analysis, and another with clinically evaluated individuals for confirmatory factor analysis. Assessments occur at baseline and one month later to evaluate test-retest reliability and other psychological measures. During the study, participants will complete various standardized questionnaires to measure mood symptoms, behavioral systems, impulsivity, and other relevant traits. The primary outcome is the performance of the HPS-6 at baseline and after one month. Secondary outcomes include psychiatric diagnostic screening and suicide behavior assessments. Participant involvement includes completing these assessments and questionnaires, with monitoring for eligibility criteria such as suicide risk and substance use disorders.

CONDITIONS